Pill Identifier App

BMS 1612 (Baraclude 1 mg)

Generic Name: entecavir

Pill imprint BMS 1612 has been identified as Baraclude 1 mg.

Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Baraclude 1 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for BMS 1612

Baraclude 1 mg BMS 1612 Front
Baraclude 1 mg BMS 1612 Back
Baraclude 1 mg BMS 1612
Baraclude 1 mg BMS 1612
Baraclude
Generic Name:
entecavir
Imprint:
BMS
1612
Strength:
1 mg
Color:
Pink
Shape:
Three-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-1612
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
crospovidone
povidone
magnesium stearate
titanium dioxide
hypromelloses
polyethylene glycol 400
ferric oxide red

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)